5AM Partners III, LLC

This profile gathers the share dealings of 5AM Partners III, LLC across 3 companies, led by Relypsa Inc, Audentes Therapeutics, Inc. and EPIRUS Biopharmaceuticals, Inc. The record holds 28 filings, for trades running from 20 November 2013 to 24 April 2017.

Market trades split into 8 purchases (€8.0M) and 2 sales (€14.4M). Netting one side against the other leaves €6.4M of net selling. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 4 share grants and 4 option exercises. So far in 2017, the count stands at 2 purchases and no sales.

Half of the purchases are above €504k and half below. On 2 out of 4 purchases, another insider of the same company was buying within the same 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.

The record was last updated on 26 April 2017 with an open-market purchase (€58k) in Audentes Therapeutics, Inc. The median gap between trade and publication is zero days: most filings appear on the same day. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.